PT Bio Farma Of Indonesia Faces Cheaper Chinese Vaccines
This article was originally published in PharmAsia News
Executive Summary
Indonesia's PT Bio Farma, a state-owned drug-maker mainstay, is preparing itself against what it calls an onslaught of competing vaccines from China over the next three years
|
Indonesia's PT Bio Farma, a state-owned drug-maker mainstay, is preparing itself against what it calls an onslaught of competing vaccines from China over the next three years. President Director Iskandar warned employees in a company anniversary speech that Chinese competition could destroy the local pharmaceutical industry, including the company, leading eventually to a takeover of the Indonesian vaccine-export market. Iskandar said the state-owned company was taking action to meet the Chinese threat of cheaper drugs, in part by solidifying its domestic distribution networks down to the village level and preparing new businesses. (Click here for more) "PT Bio Farma Facing Challenge From China" - Antara News (Indonesia) (8/6/11) |